taurine has been researched along with Thrombosis in 11 studies
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous injection of chloramine derivatives of amino acids and taurine reduced the mortality rate in mice with thrombosis induced by intravenous injection of ADP or collagen-epinephrine mixture." | 7.71 | Antithrombotic activity of N,N-dichlorotaurine on mouse model of thrombosis in vivo. ( Chudina, NA; Fesenko, OD; Murina, MA; Roshchupkin, DI; Sergienko, VI, 2002) |
| "The effects of neferine (Nef), taurine (Tau) and Nef + Tau on platelet aggregation and generation of thrombosis were investigated in rats." | 7.69 | [Effects of neferine and its combination with taurine on platelet aggregation and experimental thrombosis in rats]. ( Huang, HL; Rao, MR, 1995) |
| " Taurine (2-aminomethylsulfonic acid), which is rich in sea foods, showed antithrombotic effect in animal models of thrombosis." | 3.79 | Antithrombotic effect of taurine in healthy Japanese people may be related to an increased endogenous thrombolytic activity. ( Hamada, A; Ijiri, Y; Ikarugi, H; Ishii, H; Mori, H; Mori, M; Morishita, M; Tamura, Y; Ura, M; Yamamoto, J; Yamori, Y, 2013) |
| "Intravenous injection of chloramine derivatives of amino acids and taurine reduced the mortality rate in mice with thrombosis induced by intravenous injection of ADP or collagen-epinephrine mixture." | 3.71 | Antithrombotic activity of N,N-dichlorotaurine on mouse model of thrombosis in vivo. ( Chudina, NA; Fesenko, OD; Murina, MA; Roshchupkin, DI; Sergienko, VI, 2002) |
| "The effects of neferine (Nef), taurine (Tau) and Nef + Tau on platelet aggregation and generation of thrombosis were investigated in rats." | 3.69 | [Effects of neferine and its combination with taurine on platelet aggregation and experimental thrombosis in rats]. ( Huang, HL; Rao, MR, 1995) |
| " Episodes of acute catheter thrombosis, requirement of recombinant tissue plasminogen activator (rt-PA) and incidence of catheter-related blood stream infection (CRBSI) were recorded, along with dialysis adequacy (Kt/V), blood flow rates (BFRs) and adverse events." | 2.87 | Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study. ( Al-Ali, F; Buanan, H; Elsayed, A; Elsayed, M; Fawzy, A; Hamad, A; Hamdy, AF; Ibrahim, R; Tolba, H; Zafar Iqbal, Z, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bonkain, F | 1 |
| Stolear, JC | 1 |
| Catalano, C | 1 |
| Vandervelde, D | 1 |
| Treille, S | 1 |
| Couttenye, MM | 1 |
| Dhondt, A | 1 |
| Libertalis, M | 1 |
| Allamani, M | 1 |
| Madhoun, P | 1 |
| Van Craenenbroeck, AH | 1 |
| Vanommeslaeghe, F | 1 |
| Van Hulle, F | 1 |
| Durieux, P | 1 |
| Van Limberghen, I | 1 |
| Tielemans, C | 1 |
| Wissing, KM | 1 |
| Al-Ali, F | 1 |
| Hamdy, AF | 1 |
| Hamad, A | 1 |
| Elsayed, M | 1 |
| Zafar Iqbal, Z | 1 |
| Elsayed, A | 1 |
| Ibrahim, R | 1 |
| Tolba, H | 1 |
| Buanan, H | 1 |
| Fawzy, A | 1 |
| Reidenberg, BE | 1 |
| Wanner, C | 1 |
| Polsky, B | 1 |
| Castanheira, M | 1 |
| Shelip, A | 1 |
| Stalleicken, D | 1 |
| Pfaffle, AE | 1 |
| Ijiri, Y | 1 |
| Ikarugi, H | 1 |
| Tamura, Y | 1 |
| Ura, M | 1 |
| Morishita, M | 1 |
| Hamada, A | 1 |
| Mori, M | 1 |
| Mori, H | 1 |
| Yamori, Y | 2 |
| Ishii, H | 1 |
| Yamamoto, J | 1 |
| Murina, MA | 1 |
| Fesenko, OD | 1 |
| Sergienko, VI | 1 |
| Chudina, NA | 1 |
| Roshchupkin, DI | 1 |
| McCarty, MF | 1 |
| Wang, H | 1 |
| Ikeda, K | 1 |
| Kihara, M | 1 |
| Nara, Y | 1 |
| Horie, R | 1 |
| Huang, HL | 1 |
| Rao, MR | 1 |
| Welles, EG | 1 |
| Boudreaux, MK | 1 |
| Tyler, JW | 1 |
| Tang, Y | 1 |
| Yao, X | 1 |
| Tang, C | 1 |
| Fanciullacci, M | 1 |
| Sicuteri, F | 1 |
| Giotti, A | 1 |
| Brunetti, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Tunneled Cuffed Catheter Malfunction With Prophylactic Use of a Taurolidine Locking Solution Containing Urokinase : a Multicentric Randomized Controlled Trial[NCT02036255] | Phase 3 | 68 participants (Actual) | Interventional | 2015-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for taurine and Thrombosis
| Article | Year |
|---|---|
Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial.
Topics: Aged; Aged, 80 and over; Catheterization, Central Venous; Central Venous Catheters; Double-Blind Met | 2021 |
Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study.
Topics: Anti-Infective Agents; Catheter-Related Infections; Catheterization; Female; Fibrinolytic Agents; He | 2018 |
[Taurine as fibrinolytic agent in humans: early therapeutic observations].
Topics: Administration, Oral; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Injections, Intravenous | 1970 |
8 other studies available for taurine and Thrombosis
| Article | Year |
|---|---|
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients.
Topics: Anti-Bacterial Agents; Calcium Citrate; Catheter-Related Infections; Central Venous Catheters; Drug | 2018 |
Antithrombotic effect of taurine in healthy Japanese people may be related to an increased endogenous thrombolytic activity.
Topics: Adult; Aged; Anticoagulants; Asian People; Blood Coagulation; Cardiovascular Diseases; Female; Fibri | 2013 |
Antithrombotic activity of N,N-dichlorotaurine on mouse model of thrombosis in vivo.
Topics: Adenosine Diphosphate; Amino Acids; Animals; Chloramines; Disease Models, Animal; Fibrinolytic Agent | 2002 |
Sub-optimal taurine status may promote platelet hyperaggregability in vegetarians.
Topics: Clinical Trials as Topic; Diet, Vegetarian; Dietary Supplements; Humans; Platelet Aggregation; Tauri | 2004 |
Role of sulfur amino acids in the prevention and regression of cardiovascular diseases.
Topics: Amino Acids, Sulfur; Animals; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Cerebrovasc | 1983 |
[Effects of neferine and its combination with taurine on platelet aggregation and experimental thrombosis in rats].
Topics: 6-Ketoprostaglandin F1 alpha; Alkaloids; Animals; Benzylisoquinolines; Blood Platelets; Cholesterol; | 1995 |
Platelet, antithrombin, and fibrinolytic activities in taurine-deficient and taurine-replete cats.
Topics: Adenosine Diphosphate; Animals; Antithrombins; Blood Platelets; Cat Diseases; Cats; Collagen; Fibrin | 1993 |
Role of endothelin in thrombolysis in rat abdominal aorta.
Topics: Animals; Aorta, Abdominal; Endothelins; Fibrinolytic Agents; In Vitro Techniques; L-Lactate Dehydrog | 1998 |